The effect of COVID-19 on utilization of chronic diseases services

Objectives The aim of the present study is to evaluate the impact of Covid-19 on utilization of chronic diseases services. Methods Interrupted time-series design was used to examine the utilization of chronic diseases services before and during the Covid-19 pandemic among hospitals in Iran. Chronic...

Full description

Saved in:
Bibliographic Details
Published in:Chronic illness 2024-06, Vol.20 (2), p.309-319
Main Authors: Moradi, Ghobad, Piroozi, Bakhtiar, Khayyati, Fariba, Moradpour, Farhad, Safari, Hossein, Mohamadi Bolbanabad, Amjad, Fattahi, Hamed, Younesi, Fatemeh, Ebrazeh, Ali, Shokri, Azad
Format: Article
Language:English
Subjects:
Adult
Aged
Asthma
Asthma - epidemiology
Asthma - therapy
Chemotherapy
Chronic asthma
Chronic Disease - therapy
Chronic illnesses
Chronic obstructive pulmonary disease
COVID-19
COVID-19 - epidemiology
COVID-19 - therapy
Diabetes
Diabetes Mellitus, Type 2 - epidemiology
Diabetes Mellitus, Type 2 - therapy
Female
Heart failure
Heart Failure - epidemiology
Heart Failure - therapy
Hospitals
Humans
Interrupted Time Series Analysis
Iran - epidemiology
Male
Middle Aged
Original
Pandemics
Patient Acceptance of Health Care - statistics & numerical data
Prevention programs
Pulmonary Disease, Chronic Obstructive - epidemiology
Pulmonary Disease, Chronic Obstructive - therapy
SARS-CoV-2
Type 2 diabetes mellitus
Women
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Objectives The aim of the present study is to evaluate the impact of Covid-19 on utilization of chronic diseases services. Methods Interrupted time-series design was used to examine the utilization of chronic diseases services before and during the Covid-19 pandemic among hospitals in Iran. Chronic obstructive pulmonary disease (COPD), asthma, type 2 diabetes, heart failure, and chemotherapy were selected as a proxy to indicate the impact of Covid-19 on utilization of chronic diseases services. Data were collected in 24 sites from 12 months before the onset of Covid-19 (from March 2019 to February 2020) to 12 months during the Covid-19 pandemic (February 2020 to March 2021). Results A total of 7,039,378 services were provided, of which 51.92% were provided for women and 62.73% for >65 age group. A sudden decrease was observed in monthly utilization of services during the Covid-19 pandemic; ranging from 13.91 (95% CI = −21.73, 6.10, P = 0.001) for chemotherapy to 606.39 (95% CI = −1040.72, 172.06, P = 0.009) for heart failure services per 100 thousand population. A decrease was observed in COPD services; 15.28 services compared with the period before Covid-19. Subsequently, the monthly utilization trends of asthma, type 2 diabetes, and chemotherapy services increased significantly (P 
ISSN:1742-3953
1745-9206
DOI:10.1177/17423953231178168